FTSE creeps higher in mixed day

Blue-chip firms in the drugs and utilities sectors experienced contrasting fortunes during a lacklustre session for the FTSE 100 Index today.

Drugmakers occupied the top three spots on the risers board as sentiment improved on consolidation efforts in the European pharmaceuticals industry and news that high-profile drug Vioxx was safe enough to return to the US market.